State Street’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.57M | Sell |
961,962
-65,988
| -6% | -$245K | ﹤0.01% | 3078 |
|
|
2025
Q1 | $3.32M | Sell |
1,027,950
-84,773
| -8% | -$274K | ﹤0.01% | 3049 |
|
|
2024
Q4 | $6.2M | Sell |
1,112,723
-1,003,785
| -47% | -$5.59M | ﹤0.01% | 2872 |
|
|
2024
Q3 | $22.9M | Buy |
2,116,508
+37,232
| +2% | +$402K | ﹤0.01% | 2128 |
|
|
2024
Q2 | $43.6M | Sell |
2,079,276
-98,954
| -5% | -$2.08M | ﹤0.01% | 1740 |
|
|
2024
Q1 | $69.4M | Buy |
2,178,230
+654,240
| +43% | +$20.8M | ﹤0.01% | 1541 |
|
|
2023
Q4 | $30.9M | Sell |
1,523,990
-193,130
| -11% | -$3.91M | ﹤0.01% | 1961 |
|
|
2023
Q3 | $21.9M | Sell |
1,717,120
-333,310
| -16% | -$4.24M | ﹤0.01% | 2123 |
|
|
2023
Q2 | $37.1M | Buy |
2,050,430
+8,241
| +0.4% | +$149K | ﹤0.01% | 1852 |
|
|
2023
Q1 | $35.1M | Buy |
2,042,189
+807,031
| +65% | +$13.9M | ﹤0.01% | 1869 |
|
|
2022
Q4 | $27.4M | Buy |
1,235,158
+557,982
| +82% | +$12.4M | ﹤0.01% | 2020 |
|
|
2022
Q3 | $5.44M | Buy |
677,176
+44,651
| +7% | +$359K | ﹤0.01% | 3015 |
|
|
2022
Q2 | $4.42M | Sell |
632,525
-856,846
| -58% | -$5.98M | ﹤0.01% | 3156 |
|
|
2022
Q1 | $22.5M | Buy |
1,489,371
+229,711
| +18% | +$3.47M | ﹤0.01% | 2314 |
|
|
2021
Q4 | $27.6M | Buy |
1,259,660
+939,998
| +294% | +$20.6M | ﹤0.01% | 2231 |
|
|
2021
Q3 | $8.62M | Buy |
319,662
+154,170
| +93% | +$4.16M | ﹤0.01% | 2970 |
|
|
2021
Q2 | $3.99M | Buy |
165,492
+58,659
| +55% | +$1.41M | ﹤0.01% | 3349 |
|
|
2021
Q1 | $4.63M | Buy |
+106,833
| New | +$4.63M | ﹤0.01% | 3085 |
|